Despite the development of targeted therapy, drug resistance remains a primary hindrance
to curative treatment of various cancers. Among several novel approaches to overcome drug …

Cancer immunotherapy, especially immune checkpoint therapy, has revolutionized
therapeutic options by reactivating the host immune system. However, the efficacy varies …

Simple Summary Glioblastoma stem cells (GBMSCs), which are particularly radio-resistant
and invasive, are responsible for the high recurrence of glioblastoma (GBM). Therefore …

Cervical cancer is the fourth most commonly diagnosed cancer worldwide and, in almost all
cases is caused by infection with highly oncogenic Human Papillomaviruses (HPVs). On the …

Chronic infection by high-risk human papillomaviruses (HPV) and chronic inflammation are
factors associated with the onset and progression of several neoplasias, including cervical …

Small cell lung carcinoma (SCLC) is a highly aggressive cancer with low survival rate.
Although initial response to chemotherapy in SCLC patients is well‐rated, the treatments …

Fenamates as classical nonsteroidal anti‐inflammatory agents are widely used for relieving
pain. Preclinical studies and epidemiological data highlight their chemo‐preventive and …

For a considerable duration, cervical cancer has posed a significant risk to the well-being
and survival of women. The emergence and progression of cervical cancer have garnered …

Background This work aimed to prepare niosomal formulations of an anticancer agent
[mefenamic acid (MEF)] to enhance its cancer targeting. 131I was utilized as a radiolabeling …

Two novel Co (II) fenamato complexes containing bathocuproine (bcp), namely [Co
(bcp)(flu) 2](1) and [Co (bcp)(nif) 2](2)(flu= flufenamato, nif= niflumato) were synthesized and …